Clincosm LogoSign in Get a demo

Healthy Subjects

Showing 51 - 75 of 775
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Image Matrix CT Reconstruction

Completed
  • Healthy Subjects
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 30, 2022

    Bioequivalence, Healthy Subjects Trial in Amman (Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium

    Completed
    • Bioequivalence
    • Healthy Subjects
    • Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
    • Nurofen® Forte Express, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
    • Amman, Jordan
      ACDIMA Center for Bioequivalence and Pharmaceutical Studies
    Dec 15, 2022

    Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated

    Completed
    • Bioequivalence
    • Healthy Subjects
    • Efez 50 mg eplerenone film-coated tablets
    • INSPRA® 50 mg eplerenone film-coated tablets
    • Amman, Jordan
      ACDIMA Center for Bioequivalence and Pharmaceutical Studies
    Dec 15, 2022

    Healthy Subjects Trial (Midazolam Syrup, HEC74647PA, HEC110114)

    Completed
    • Healthy Subjects
    • Midazolam Syrup
    • +2 more
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Dec 20, 2022

    Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of

    Completed
    • Methylprednisone Administration
    • +3 more
    • Evaluation of bioavailability of methylprednisolone succinate administered intravenously
    • Evaluation of bioavailability of methylprednisolone succinate administered intranasally
    • Mexico City, Mexico
      Universidad Nacional Autonoma de Mexico
    Dec 13, 2022

    Dexamethasone Administration, Intranasal Administration, Inflammation Trial in Mexico City (Dexamethasone)

    Completed
    • Dexamethasone Administration
    • +4 more
    • Mexico City, Mexico
      Universidad Nacional Autonoma de Mexico
    Dec 9, 2022

    Healthy Subjects Trial in Glendale (Nintedanib, AZD5055)

    Not yet recruiting
    • Healthy Subjects
    • Glendale, United Kingdom
      Research Site
    Dec 1, 2022

    Healthy Subjects Trial in Lausanne (ACT-132577, Placebo)

    Completed
    • Healthy Subjects
    • Lausanne, Switzerland
      Investigator Site Lausanne
    Nov 22, 2022

    Healthy Subjects Trial in Plzen (ACT-132577, Rosuvastatin)

    Completed
    • Healthy Subjects
    • Plzen, Czechia
      Cepha s.r.o
    Nov 22, 2022

    Healthy Subjects Trial in Nanjing ([14C] IBI351)

    Not yet recruiting
    • Healthy Subjects
    • [14C] IBI351
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Nov 15, 2022

    Healthy Subjects Trial in Anaheim (Aprocitentan 25mg, Placebo)

    Completed
    • Healthy Subjects
    • Aprocitentan 25mg
    • Placebo
    • Anaheim, California
      Anaheim Clinical Trials
    Nov 22, 2022

    Healthy Subjects Trial in Mannheim (Aprocitentan 25 mg, Aprocitentan 100 mg, Matching )

    Completed
    • Healthy Subjects
    • Aprocitentan 25 mg
    • +3 more
    • Mannheim, Baden-Württemberg, Germany
      CRS Clinical Research Services Mannheim GmbH
    Nov 22, 2022

    Hepatic Impairment, Healthy Subjects Trial in Kiel, Jozefow (Aprocitentan)

    Completed
    • Hepatic Impairment
    • Healthy Subjects
    • Kiel, Germany
    • +1 more
    Nov 22, 2022

    Healthy Subjects Trial in Overland Park (Selatogrel)

    Completed
    • Healthy Subjects
    • Selatogrel
    • Overland Park, Kansas
      Altasciences Clinical Kansas, Inc
    Nov 15, 2022

    Healthy Subjects Trial in Rennes (Combined oral contraceptives (COC), Moxifloxacin 400mg, Cenerimod 0.5 mg)

    Completed
    • Healthy Subjects
    • Combined oral contraceptives (COC)
    • +5 more
    • Rennes, France
      Site 1
    Nov 15, 2022

    Healthy Subjects Trial in Seoul (CT-P47)

    Recruiting
    • Healthy Subjects
    • CT-P47
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 13, 2022

    Healthy Subjects Trial in Boston (Inhaled Nitric Oxide)

    Not yet recruiting
    • Healthy Subjects
    • Inhaled Nitric Oxide
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 9, 2022

    Healthy Subjects Trial in Madison (AMG 510)

    Completed
    • Healthy Subjects
    • AMG 510
    • Madison, Wisconsin
      Covance Clinical Research Unit, Inc
    Nov 3, 2022

    Healthy Subjects Trial in Málaga (Aerobic or anaerobic exercise)

    Active, not recruiting
    • Healthy Subjects
    • Aerobic or anaerobic exercise
    • Málaga, Spain
      Hospital Universitario Virgen de la Victoria
    Oct 31, 2022

    Genetic & Environmental Determinants Of Immune Phenotype

    Active, not recruiting
    • Healthy Subjects
    • Human Biological Samples
    • Rennes, France
      Biotrial
    Oct 27, 2022

    Healthy Subjects Trial in Cheongju-si (SID1903 (FDC), Dapagliflozin and Sitagliptin)

    Completed
    • Healthy Subjects
    • SID1903 (FDC)
    • Dapagliflozin and Sitagliptin
    • Cheongju-si, Korea, Republic of
      Chungbuk National University Hospital
    Oct 24, 2022

    Healthy Subjects Trial in Qingdao (XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin

    Not yet recruiting
    • Healthy Subjects
    • XZP-3621 tablet and itraconazole oral liquid (for Arm1)
    • +2 more
    • Qingdao, Shan Dong, China
      The Affiliated Hospital of Qingdao University
    Oct 16, 2022

    Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)

    Completed
    • Healthy Subjects
    • Toshima-ku, Japan
      Taisho Pharmaceutical Co., Ltd selected site
    Oct 5, 2022

    Healthy Subjects Trial in Tokyo (TS-142, Itraconazole)

    Completed
    • Healthy Subjects
    • Tokyo, Japan
      Taisho Pharmaceutical Co., Ltd selected site
    Oct 4, 2022

    Healthy Subjects, Chronic Conditions, Multiple Trial in Millcreek, Jerusalem (Neteera 130H)

    Completed
    • Healthy Subjects
    • Chronic Conditions, Multiple
    • Neteera 130H
    • Millcreek, Utah
    • +1 more
    Oct 4, 2022